Hämostaseologie

1.4k papers and 8.3k indexed citations i.

About

The 1.4k papers published in Hämostaseologie in the last decades have received a total of 8.3k indexed citations. Papers published in Hämostaseologie usually cover Hematology (687 papers), Cardiology and Cardiovascular Medicine (340 papers) and Internal Medicine (314 papers) specifically the topics of Platelet Disorders and Treatments (338 papers), Venous Thromboembolism Diagnosis and Management (314 papers) and Hemophilia Treatment and Research (254 papers). The most active scholars publishing in Hämostaseologie are Rüdiger E. Scharf, Johannes Oldenburg, Marcel Levi, Florian Länger, Cihan Ay, Anton J.G. Horrevoets, Reinier A. Boon, Ingrid Pabinger, Jun Xu and Charles T. Esmon.

In The Last Decade

Fields of papers published in Hämostaseologie

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Hämostaseologie. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Hämostaseologie

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Hämostaseologie. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Hämostaseologie with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025